Literature DB >> 20193108

Technology update for the sorting and identification of breast cancer stem cells.

Jian Chen1, Zeng-Liang Chen.   

Abstract

Breast cancer stem cells are a group of undifferentiated cells with self-renewal and multidifferentiation potential. Chemotherapeutic and radiotherapeutic resistance, hypoxic resistance, high tumorigenicity, high cell invasion, and metastatic abilities are characteristics of these cells, which are responsible for breast cancer recurrence. Therefore, the correct sorting and identification of breast cancer stem cells is a primary step for research in this field. This article briefly describes the recent progress on sorting and identification technologies for breast cancer stem cells. Sorting technologies include the side population technique, technologies that depend on cell surface markers, ALDEFLUOR assays, and in situ detection. Identification technologies include mammosphere cultures, limited dilution in vitro, and in-vivo animal models. This review provides an important reference for breast cancer stem cell research, which will explore new methods for the treatment of patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20193108     DOI: 10.5732/cjc.009.10642

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN: 1944-446X


  3 in total

Review 1.  Clinical application of circulating tumor cells in breast cancer.

Authors:  Leonie H A Broersen; Gabi W van Pelt; Rob A E M Tollenaar; Wilma E Mesker
Journal:  Cell Oncol (Dordr)       Date:  2013-11-19       Impact factor: 6.730

Review 2.  Stem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) Cells.

Authors:  Pier M Biava; Silvia Canaider; Federica Facchin; Eva Bianconi; Liza Ljungberg; Domenico Rotilio; Fabio Burigana; Carlo Ventura
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

Review 3.  Road to stemness in hepatocellular carcinoma.

Authors:  Teresita Nj Flores-Téllez; Saúl Villa-Treviño; Carolina Piña-Vázquez
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.